About
CEO and co-founder of BioAge, a clinical-stage biotechnology company developing a…
Activity
-
BioAge Labs appoints former GSK CEO as Chair of Board of Directors Veteran pharmaceutical executive Jean-Pierre Garnier to lead Board as BioAge…
BioAge Labs appoints former GSK CEO as Chair of Board of Directors Veteran pharmaceutical executive Jean-Pierre Garnier to lead Board as BioAge…
Liked by Kristen Fortney
-
We are excited to welcome our new Program Manager, Dr. Jean Hebert! Welcome to the team! #ARPAHGetsToWork https://lnkd.in/eHC3i35U
We are excited to welcome our new Program Manager, Dr. Jean Hebert! Welcome to the team! #ARPAHGetsToWork https://lnkd.in/eHC3i35U
Liked by Kristen Fortney
-
We are proud to have partnered with BioAge Labs on the appointment of Jean-Pierre Garnier to Chair of the Board of Directors. https://lnkd.in/gJ7gQ5i4
We are proud to have partnered with BioAge Labs on the appointment of Jean-Pierre Garnier to Chair of the Board of Directors. https://lnkd.in/gJ7gQ5i4
Liked by Kristen Fortney
Experience
Education
Publications
-
Drug repurposing using deep embeddings of gene expression profiles
Molecular pharmaceutics 15 (10)
Authors: Donner, Y., Kazmierczak, S., Fortney, K.
-
MortalityPredictors. org: a manually-curated database of published biomarkers of human all-cause mortality
Aging (Albany NY) 9 (8)
Authors: Peto, M. V., De la Guardia, C., Winslow, K., Ho, A., Fortney, K., Morgen, E.
-
Great desire for extended life and health amongst the American public
Frontiers in Genetics 6(353)
Authors: Donner, Y., Fortney, K., Calimport, S. R. G., Pfleger, K., Shah, M., and Betts-LaCroix, J.
-
Genome-wide scan informed by age-related disease identifies new loci for exceptional human longevity
PLoS Genetics 11(12)
Authors: Fortney, K., Dobriban, E., Garagnani, P., Pirazzini, C., Monti, D., Mari, D., Atzmon, G., Barzilai, N., Franceschi, C., Owen, A. B., and Kim, S. K.
-
Optimal Multiple Testing Under a Gaussian Prior on the Effect Sizes
Biometrika 102(4)
Authors: Dobriban, E., Fortney, K., Kim, S. K., Owen, A. B.
-
Prioritizing Therapeutics for Lung Cancer: An Integrative Meta-analysis of Cancer Gene Signatures and Chemogenomic Data
PLoS Computational Biology 11(3): e1004068
Authors: Fortney, K., Griesman, J., Kotlyar, M., Pastrello, C., Angeli, M., Sound-Tsao, M., and Jurisica, I.
-
Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cells
Oncotarget 6(27)
Authors: Makarev, E., Fortney, K., Litovchenko, M., Braunewell, K., Zhavoronkov, A., and Atala, A.
-
Whole-Genome Sequencing of the World’s Oldest People
PLoS ONE 9(11): e112430
Authors: Gierman H.J., Fortney K., Roach J.C., Coles N.S., Li H., Glusman G., Markov G.J., Smith J.D., Hood L., Coles L.S., and Kim S.K.
-
NetwoRx: Connecting drugs to networks and phenotypes in S. Cerevisiae
Nucleic Acids Research 41:D720-7
Authors: Fortney, K., Xie, W., Kotlyar, M., Griesman, J., and Jurisica, I.
-
Resistance to genotoxic stresses in Arctica islandica, the longest-living non-colonial animal: is extreme longevity associated with a multi-stress resistance phenotype?
Journals of Gerontology: Biological Sciences 68(5)
Authors: Ungvari, Z., Sosnowska, D., Mason, J.B., Gruber, H., Lee, S.W., Schwartz, T.S., Brown, M.K., Storm, N.J., Fortney, K., Sowa, J., Byrne, A.B., Kurz, T., Levy, E., Sonntag, W.E., Austad, S.N., Csiszar, A., Ridgway, I.
-
Visualizing biological networks: one size does not fit all
PLoS Computational Biology 9(1):e1002833
Authors: Pastrello, C., Otasek, D., Fortney, K., Agapito, G., Cannataro, M., Shirdel, E., and Jurisica, I.
-
Computational advantages of reverberating loops for sensorimotor learning
Neural Computation 24(3)
Authors: Fortney, K., and Tweed, D.
-
In silico drug screen in mouse liver identifies candidate calorie restriction mimetics
Rejuvenation Research 15(2)
Authors: Fortney, K., Morgen, E., Kotlyar, M., and Jurisica, I.
-
Network-based characterization of drug-regulated genes, drug targets, and toxicity
Methods 57(4)
Authors: Kotlyar, M., Fortney, K., and Jurisica, I
-
Integrative computational biology for cancer research
Human Genetics 130(4):465-81
Authors: Fortney, K., and Jurisica, I.
-
NAViGaTOR: Scalable and Interactive Navigation and Analysis of Large Graphs
Internet Mathematics 7(4)
Authors: Djebbari, A., Ali, M., Otasek, D., Kotlyar, M., Fortney, K., Wong, S., Hrvojic, A., and Jurisica, I.
-
Inferring the functions of longevity genes with modular subnetwork biomarkers of Caenorhabditis elegans aging
Genome Biology 11(2):R13
Authors: Fortney, K., Kotlyar, M., and Jurisica, I
Honors & Awards
-
Glenn Award for Research in Biological Mechanisms of Aging
Glenn Foundation For Medical Research
-
Postdoctoral Fellowship in Aging Research
Ellison Medical Foundation / American Federation for Aging Research
-
Dean's Postdoctoral Fellowship
Stanford University
More activity by Kristen
-
BioAge is pleased to announce the appointment of Jean Pierre Garnier, PhD, as Chair of our Board of Directors. Dr. Garnier, who served as CEO of GSK…
BioAge is pleased to announce the appointment of Jean Pierre Garnier, PhD, as Chair of our Board of Directors. Dr. Garnier, who served as CEO of GSK…
Liked by Kristen Fortney
-
This is a funny list to be on - next billion dollar company. But honestly, I think this is a big win for women's health. Almost every company on the…
This is a funny list to be on - next billion dollar company. But honestly, I think this is a big win for women's health. Almost every company on the…
Liked by Kristen Fortney
-
I have started, built, and exited several biotech companies (over $6B in exit value). Unusually, my companies are started as university spin-outs. I…
I have started, built, and exited several biotech companies (over $6B in exit value). Unusually, my companies are started as university spin-outs. I…
Liked by Kristen Fortney
-
At the #12thPeptoidSummit, Dr. Mark Kline spoke about advances in organ transplant science in his lecture, "Halting Time: The Peptoid Path to Ending…
At the #12thPeptoidSummit, Dr. Mark Kline spoke about advances in organ transplant science in his lecture, "Halting Time: The Peptoid Path to Ending…
Liked by Kristen Fortney
-
Announcing the launch of our flagship viable bone matrix product, OssiGraft Prime
Announcing the launch of our flagship viable bone matrix product, OssiGraft Prime
Liked by Kristen Fortney
-
🚀 Exciting News at Pauling.AI! 🎉 We are thrilled to announce that Flex Capital has joined our seed round investment! This partnership marks a…
🚀 Exciting News at Pauling.AI! 🎉 We are thrilled to announce that Flex Capital has joined our seed round investment! This partnership marks a…
Liked by Kristen Fortney
-
I am excited to share that Gameto has been nominated for the Best Startup Award by The Galien Foundation! This recognition highlights the commitment…
I am excited to share that Gameto has been nominated for the Best Startup Award by The Galien Foundation! This recognition highlights the commitment…
Liked by Kristen Fortney
-
Thanks NYSE for featuring Abdera Therapeutics on the Trading Floor as you highlighted this year's #Fierce15 Biotech companies!
Thanks NYSE for featuring Abdera Therapeutics on the Trading Floor as you highlighted this year's #Fierce15 Biotech companies!
Liked by Kristen Fortney
-
Great to talk AI for drug discovery Andrew Ross Sorkin on CNBC. There is no more impactful use of AI than improving human health. Delighted for the…
Great to talk AI for drug discovery Andrew Ross Sorkin on CNBC. There is no more impactful use of AI than improving human health. Delighted for the…
Liked by Kristen Fortney
-
Congratulations to the team on the IND approval and orphan drug designation from the US FDA for ISM6331, an AI-designed non-covalent pan-TEAD…
Congratulations to the team on the IND approval and orphan drug designation from the US FDA for ISM6331, an AI-designed non-covalent pan-TEAD…
Liked by Kristen Fortney
-
We are very pleased to share positive data from our Phase 1/2 EXPLORE44™ trial for people living with Duchenne muscular dystrophy mutations amenable…
We are very pleased to share positive data from our Phase 1/2 EXPLORE44™ trial for people living with Duchenne muscular dystrophy mutations amenable…
Liked by Kristen Fortney
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Kristen Fortney in United States
-
Kristen Fortney
-
Kristen Fortney
Teacher at Trinity Christian Academy
-
Kristen Fortney
Bartender
-
Kristen Fortney
Student at Arizona State University
8 others named Kristen Fortney in United States are on LinkedIn
See others named Kristen Fortney